"Nonetheless, there has been a recent rash of interest in the tubes. One of the believers is George Okafo, a director of emerging platforms at the drug company GlaxoSmithKline (GSK) in Stevenage, UK. He thinks that cell-to-cell protrusions could explain why diseases such as Alzheimer's disease, Parkinson's disease and malaria, as well as HIV and prion infections, are so difficult to treat..."
Monya Baker, How the Internet of cells has biologists buzzing. Nature, 20 September 2017

No comments:
Post a Comment
Add a comment